文献速递神经肿瘤

靶向hTERT前体mRNA内含子剪接增强子的反义寡核苷酸抑制胶质瘤端粒酶并诱导凋亡

A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells.
PubMed 文献 · J Neurooncol · 2019-03-18

研究探讨hTERT前体mRNA可变剪接对端粒酶活性的调控,并设计靶向内含子剪接增强子(ISE)的反义寡核苷酸(AON)AON-Ex726。在胶质瘤细胞中,AON-Ex726改变hTERT剪接模式,降低全长hTERT mRNA、增加-β hTERT mRNA,导致端粒酶活性和细胞增殖显著下降、凋亡增加。生物信息学提示AON-Ex726锚定序列与SRSF2结合位点重叠。

要点

  • 胶质瘤细胞系和患者组织中均存在hTERT前体mRNA剪接。
  • 端粒酶活性与全长hTERT表达水平相关,而非总hTERT转录本水平。
  • AON-Ex726改变hTERT剪接,降低端粒酶活性与增殖并增加凋亡。

核心结论

  • 调控hTERT前体mRNA可变剪接模式可为胶质瘤基因治疗提供新靶点与线索。

研究设计与样本

  • 研究采用RT-PCR检测胶质瘤细胞系和脑组织中hTERT剪接,TRAP法检测端粒酶活性。
  • 设计并合成2'-O-甲基-RNA硫代磷酸反义寡核苷酸(AON)转染胶质瘤细胞。
  • 采用MTT、平板克隆形成、western blotting和Annexin V/PI检测增殖与凋亡。
  • 采用生物信息学分析预测剪接蛋白SRSF2在胶质瘤中的表达与功能。

主要发现

  • hTERT剪接在胶质瘤细胞系和胶质瘤患者组织中均发生。
  • 端粒酶活性与全长hTERT表达水平相关,而非总hTERT转录本水平。
  • AON-Ex726与内含子6中ISE序列互补,显著改变hTERT前体mRNA剪接模式。
  • AON-Ex726降低全长hTERT mRNA表达水平并增加-β hTERT mRNA表达水平。
  • 转染AON-Ex726后凋亡水平增加,端粒酶活性和细胞增殖显著降低。

关键数值与推荐

  • 生物信息学预测显示AON-Ex726在ISE的锚定序列与SRSF2蛋白结合位点重叠,SRSF2在胶质瘤发生发展中上调。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Alternative splicing of hTERT pre-mRNA is an important step in the regulation of telomerase activity, but the regulation mechanisms and functions remain unclear. METHODS: RT-PCR analysis was used to detect hTERT splicing in glioma cell lines and brain tissues. TRAP assay was used to detect the telomerase activity. Then, we designed and synthesized 2'-O-methyl-RNA phosphorothioate AONs and transfected them into glioma cells to detect the changes in telomerase activity. MTT assay, plate colony formation assay, western blotting and Annexin V/PI assay were used to detect cell proliferation and apoptosis. At last, bioinformatics analyses were used to predict the expression and function of splicing protein SRSF2 in gliomas. RESULTS: hTERT splicing occurs both in glioma cell lines and glioma patients' tissues. The telomerase activity was related to the expression level of the full-length hTERT, rather than the total hTERT transcript level. AON-Ex726 was complementary to the sequence of the intronic splicing enhancer (ISE) in intron six, and significantly altered the splicing pattern of hTERT pre-mRNA, reducing the expression level of the full-length hTERT mRNA and increasing the expression level of the -β hTERT mRNA. After transfection with AON-Ex726, the level of apoptosis was increased, while telomerase activity and cell proliferation were significantly decreased. By bioinformatic predictions, we found the AON-Ex726 anchoring sequence in ISE overlaps the binding site of SRSF2 protein, which is up-regulated during the development of gliomas. CONCLUSIONS: Our findings provided new targets and important clues for the gene therapy of gliomas by regulating the alternative splicing pattern of hTERT pre-mRNA.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Wang F, Cheng Y, Zhang C, et al. A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells. J Neurooncol. 2019. PMID: 30887243. doi:10.1007/s11060-019-03150-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。